American Society of Hirudotherapy

Healing with integrative management of Diabetic foot ulcer — A case report

Katkar R, Aadithyaraj KT, Rana U (2025) · Journal of Ayurveda and Integrative Medicine · 1 patient

Case-level evidence: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

Study Profile

Design
single-patient Ayurveda integrative-management case report of a 50-year-old male with a 2-month plantar diabetic foot ulcer; multi-modal Vrana upkrama protocol including Jalaukavacharana (leech application), Parisheka (medicated streaming), and Vrana ropana (wound-healing measures); AIIMS Rishikesh + All India Institute of Ayurveda (New Delhi) + Banaras Hindu University
Patient
1
Presentation and intervention
Jalaukavacharana (medicinal-leech bloodletting) combined with Vrana shodhana (medicated decoction streaming), Vrana ropana (wound-healing), and Shamana (palliative Ayurvedic therapy) over 3 months for plantar DFU
Outcome
Integrated Ayurveda DFU protocol with jalauka (leech) bloodletting reduced healing time and improved DMIST wound-quality scores compared to baseline; authors report reduced amputation risk and improved patient quality of life; integrative protocol presented as a complementary approach when conventional management is insufficient
Follow-up duration
3 months

Key Findings

  • AIIMS Rishikesh case report of integrative Ayurveda DFU management including leech bloodletting
  • 3-month outcomes show reduced healing time and improved DMIST wound quality scores
  • Multi-modal protocol (jalauka + parisheka + vrana ropana + shamana) — leech component not isolated
  • Adds to Indian leech-DFU literature alongside Bopparathi 2023
  • Documents tertiary-center Indian academic Ayurveda DFU practice

Limitations

  • Single patient (n=1) — cannot establish generalizable efficacy
  • Multi-modal protocol cannot isolate leech-therapy contribution
  • No blinded outcome adjudication
  • DMIST tool reported without baseline-blinded comparator
  • 3-month follow-up insufficient for ulcer-recurrence assessment

Clinical Implications

Katkar 2025 adds an AIIMS-level Indian academic-medicine case report to the existing leech-DFU literature. For ASH, the case does not support extending US K040187 clinical practice to DFU but illustrates how integrative-medicine programs in India (AIIMS, BHU) document leech-therapy use in chronic-wound contexts. The case supports the broader need for properly powered DFU leech RCTs and integrative-medicine outcome standardization.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.